ArticleRadiology. Imaging cancer2021
Assessment of Early Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer Using Amide Proton Transfer-weighted Chemical Exchange Saturation Transfer MRI: A Pilot Study.
Abstract read
In one paragraph
Article in Radiology. Imaging cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Detection of breast cancer lesions using APT weighted MRI: a systematic review.Journal of translational medicine · 2025Pooled it
- CEST-MRI assessment of locally advanced pMMR rectal cancer for prediction of immune activation status following radiotherapy.European radiology · 2026Article
- Multimodal imaging and artificial intelligence for response assessment to neoadjuvant therapy in breast cancer: a comprehensive review.NPJ breast cancer · 2026Review
- Comparison of postprocessing metrics in multimetabolic APT-weighted CEST and 2-deoxy-D-glucose-CEST-MRI for differentiating breast cancer subtypes in a murine model.European radiology experimental · 2026Article
- Volumetric histogram analysis of amide proton transfer-weighted imaging for predicting complete tumor response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma.European radiology · 2025Article
- Assessment of Hypoxia in Breast Cancer: Emerging Functional MR Imaging and Spectroscopy Techniques and Clinical Applications.Journal of magnetic resonance imaging : JMRI · 2025Review
- Development and Validation of Four Different Methods to Improve MRI-CEST Tumor pH Mapping in Presence of Fat.Journal of imaging · 2024Article
- Quasi-steady-state (QUASS) reconstruction enhances TMagnetic resonance in medicine · 2024Article
- Multiparametric MRI for characterization of the tumour microenvironment.Nature reviews. Clinical oncology · 2024Review
- Article
- Ultrafast dynamic contrast-enhanced breast MRI with quantitative perfusion parameters in differentiating breast cancer: a study focusing on triple-negative and HER2 positive breast cancer.Frontiers in oncology · 2024Article
- Early prediction of pathological response to neoadjuvant chemotherapy of breast tumors: a comparative study using amide proton transfer-weighted, diffusion weighted and dynamic contrast enhanced MRI.Frontiers in medicine · 2024Article
- Metabolic Imaging as a Tool to Characterize Chemoresistance and Guide Therapy in Triple-Negative Breast Cancer (TNBC).Molecular cancer research : MCR · 2023Article
- A machine learning approach that measures pH using acidoCEST MRI of iopamidol.NMR in biomedicine · 2023Article
- Multiparametric chemical exchange saturation transfer MRI detects metabolic changes in breast cancer following immunotherapy.Journal of translational medicine · 2023Article
- A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast Cancer.Radiology. Imaging cancer · 2023Article
- CEST-MRI for body oncologic imaging: are we there yet?NMR in biomedicine · 2023Review
- Radiomics, deep learning and early diagnosis in oncology.Emerging topics in life sciences · 2021Review
- A Brief History and Future Prospects of CEST MRI in Clinical Non-Brain Tumor Imaging.International journal of molecular sciences · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Shu ZhangFrom the Departments of Cancer Systems Imaging (S.Z., A.K., M.D.P.), Abdominal Imaging (G.M.R., R.M.M.M., A.H.A., N.A.E.), Breast Imaging (B.E.A., M.B.), Imaging Physics (J.B.S., B.C.M., K.P.H., J.M., M.D.P.), Biostatistics (J.S., P.W.), and Breast Medical Oncology (J.B.W.), University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054; Department of Global MR Applications & Workflow, GE Healthcare Japan, Tokyo, Japan (M.M.); and Department of Global MR Applications & Workflow, GE Healthcare, Houston, TX (X.W.).ORCID 0000-0003-0433-1977
Gaiane M RauchFrom the Departments of Cancer Systems Imaging (S.Z., A.K., M.D.P.), Abdominal Imaging (G.M.R., R.M.M.M., A.H.A., N.A.E.), Breast Imaging (B.E.A., M.B.), Imaging Physics (J.B.S., B.C.M., K.P.H., J.M., M.D.P.), Biostatistics (J.S., P.W.), and Breast Medical Oncology (J.B.W.), University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054; Department of Global MR Applications & Workflow, GE Healthcare Japan, Tokyo, Japan (M.M.); and Department of Global MR Applications & Workflow, GE Healthcare, Houston, TX (X.W.).ORCID 0000-0003-2079-5202
Beatriz E AdradaFrom the Departments of Cancer Systems Imaging (S.Z., A.K., M.D.P.), Abdominal Imaging (G.M.R., R.M.M.M., A.H.A., N.A.E.), Breast Imaging (B.E.A., M.B.), Imaging Physics (J.B.S., B.C.M., K.P.H., J.M., M.D.P.), Biostatistics (J.S., P.W.), and Breast Medical Oncology (J.B.W.), University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054; Department of Global MR Applications & Workflow, GE Healthcare Japan, Tokyo, Japan (M.M.); and Department of Global MR Applications & Workflow, GE Healthcare, Houston, TX (X.W.).ORCID 0000-0002-5539-5332
Medine BogeFrom the Departments of Cancer Systems Imaging (S.Z., A.K., M.D.P.), Abdominal Imaging (G.M.R., R.M.M.M., A.H.A., N.A.E.), Breast Imaging (B.E.A., M.B.), Imaging Physics (J.B.S., B.C.M., K.P.H., J.M., M.D.P.), Biostatistics (J.S., P.W.), and Breast Medical Oncology (J.B.W.), University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054; Department of Global MR Applications & Workflow, GE Healthcare Japan, Tokyo, Japan (M.M.); and Department of Global MR Applications & Workflow, GE Healthcare, Houston, TX (X.W.).
Rania M M MohamedFrom the Departments of Cancer Systems Imaging (S.Z., A.K., M.D.P.), Abdominal Imaging (G.M.R., R.M.M.M., A.H.A., N.A.E.), Breast Imaging (B.E.A., M.B.), Imaging Physics (J.B.S., B.C.M., K.P.H., J.M., M.D.P.), Biostatistics (J.S., P.W.), and Breast Medical Oncology (J.B.W.), University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054; Department of Global MR Applications & Workflow, GE Healthcare Japan, Tokyo, Japan (M.M.); and Department of Global MR Applications & Workflow, GE Healthcare, Houston, TX (X.W.).
Abeer H AbdelhafezFrom the Departments of Cancer Systems Imaging (S.Z., A.K., M.D.P.), Abdominal Imaging (G.M.R., R.M.M.M., A.H.A., N.A.E.), Breast Imaging (B.E.A., M.B.), Imaging Physics (J.B.S., B.C.M., K.P.H., J.M., M.D.P.), Biostatistics (J.S., P.W.), and Breast Medical Oncology (J.B.W.), University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054; Department of Global MR Applications & Workflow, GE Healthcare Japan, Tokyo, Japan (M.M.); and Department of Global MR Applications & Workflow, GE Healthcare, Houston, TX (X.W.).
Jong Bum SonFrom the Departments of Cancer Systems Imaging (S.Z., A.K., M.D.P.), Abdominal Imaging (G.M.R., R.M.M.M., A.H.A., N.A.E.), Breast Imaging (B.E.A., M.B.), Imaging Physics (J.B.S., B.C.M., K.P.H., J.M., M.D.P.), Biostatistics (J.S., P.W.), and Breast Medical Oncology (J.B.W.), University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054; Department of Global MR Applications & Workflow, GE Healthcare Japan, Tokyo, Japan (M.M.); and Department of Global MR Applications & Workflow, GE Healthcare, Houston, TX (X.W.).ORCID 0000-0003-2548-5895
Jia SunFrom the Departments of Cancer Systems Imaging (S.Z., A.K., M.D.P.), Abdominal Imaging (G.M.R., R.M.M.M., A.H.A., N.A.E.), Breast Imaging (B.E.A., M.B.), Imaging Physics (J.B.S., B.C.M., K.P.H., J.M., M.D.P.), Biostatistics (J.S., P.W.), and Breast Medical Oncology (J.B.W.), University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054; Department of Global MR Applications & Workflow, GE Healthcare Japan, Tokyo, Japan (M.M.); and Department of Global MR Applications & Workflow, GE Healthcare, Houston, TX (X.W.).
Nabil A ElshafeeyFrom the Departments of Cancer Systems Imaging (S.Z., A.K., M.D.P.), Abdominal Imaging (G.M.R., R.M.M.M., A.H.A., N.A.E.), Breast Imaging (B.E.A., M.B.), Imaging Physics (J.B.S., B.C.M., K.P.H., J.M., M.D.P.), Biostatistics (J.S., P.W.), and Breast Medical Oncology (J.B.W.), University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054; Department of Global MR Applications & Workflow, GE Healthcare Japan, Tokyo, Japan (M.M.); and Department of Global MR Applications & Workflow, GE Healthcare, Houston, TX (X.W.).
Jason B WhiteFrom the Departments of Cancer Systems Imaging (S.Z., A.K., M.D.P.), Abdominal Imaging (G.M.R., R.M.M.M., A.H.A., N.A.E.), Breast Imaging (B.E.A., M.B.), Imaging Physics (J.B.S., B.C.M., K.P.H., J.M., M.D.P.), Biostatistics (J.S., P.W.), and Breast Medical Oncology (J.B.W.), University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054; Department of Global MR Applications & Workflow, GE Healthcare Japan, Tokyo, Japan (M.M.); and Department of Global MR Applications & Workflow, GE Healthcare, Houston, TX (X.W.).
Benjamin C MusallFrom the Departments of Cancer Systems Imaging (S.Z., A.K., M.D.P.), Abdominal Imaging (G.M.R., R.M.M.M., A.H.A., N.A.E.), Breast Imaging (B.E.A., M.B.), Imaging Physics (J.B.S., B.C.M., K.P.H., J.M., M.D.P.), Biostatistics (J.S., P.W.), and Breast Medical Oncology (J.B.W.), University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054; Department of Global MR Applications & Workflow, GE Healthcare Japan, Tokyo, Japan (M.M.); and Department of Global MR Applications & Workflow, GE Healthcare, Houston, TX (X.W.).
Mitsuharu MiyoshiFrom the Departments of Cancer Systems Imaging (S.Z., A.K., M.D.P.), Abdominal Imaging (G.M.R., R.M.M.M., A.H.A., N.A.E.), Breast Imaging (B.E.A., M.B.), Imaging Physics (J.B.S., B.C.M., K.P.H., J.M., M.D.P.), Biostatistics (J.S., P.W.), and Breast Medical Oncology (J.B.W.), University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054; Department of Global MR Applications & Workflow, GE Healthcare Japan, Tokyo, Japan (M.M.); and Department of Global MR Applications & Workflow, GE Healthcare, Houston, TX (X.W.).
Xinzeng WangFrom the Departments of Cancer Systems Imaging (S.Z., A.K., M.D.P.), Abdominal Imaging (G.M.R., R.M.M.M., A.H.A., N.A.E.), Breast Imaging (B.E.A., M.B.), Imaging Physics (J.B.S., B.C.M., K.P.H., J.M., M.D.P.), Biostatistics (J.S., P.W.), and Breast Medical Oncology (J.B.W.), University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054; Department of Global MR Applications & Workflow, GE Healthcare Japan, Tokyo, Japan (M.M.); and Department of Global MR Applications & Workflow, GE Healthcare, Houston, TX (X.W.).
Aikaterini KotrotsouFrom the Departments of Cancer Systems Imaging (S.Z., A.K., M.D.P.), Abdominal Imaging (G.M.R., R.M.M.M., A.H.A., N.A.E.), Breast Imaging (B.E.A., M.B.), Imaging Physics (J.B.S., B.C.M., K.P.H., J.M., M.D.P.), Biostatistics (J.S., P.W.), and Breast Medical Oncology (J.B.W.), University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054; Department of Global MR Applications & Workflow, GE Healthcare Japan, Tokyo, Japan (M.M.); and Department of Global MR Applications & Workflow, GE Healthcare, Houston, TX (X.W.).
Peng WeiFrom the Departments of Cancer Systems Imaging (S.Z., A.K., M.D.P.), Abdominal Imaging (G.M.R., R.M.M.M., A.H.A., N.A.E.), Breast Imaging (B.E.A., M.B.), Imaging Physics (J.B.S., B.C.M., K.P.H., J.M., M.D.P.), Biostatistics (J.S., P.W.), and Breast Medical Oncology (J.B.W.), University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054; Department of Global MR Applications & Workflow, GE Healthcare Japan, Tokyo, Japan (M.M.); and Department of Global MR Applications & Workflow, GE Healthcare, Houston, TX (X.W.).ORCID 0000-0001-7758-6116
Ken-Pin HwangFrom the Departments of Cancer Systems Imaging (S.Z., A.K., M.D.P.), Abdominal Imaging (G.M.R., R.M.M.M., A.H.A., N.A.E.), Breast Imaging (B.E.A., M.B.), Imaging Physics (J.B.S., B.C.M., K.P.H., J.M., M.D.P.), Biostatistics (J.S., P.W.), and Breast Medical Oncology (J.B.W.), University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054; Department of Global MR Applications & Workflow, GE Healthcare Japan, Tokyo, Japan (M.M.); and Department of Global MR Applications & Workflow, GE Healthcare, Houston, TX (X.W.).
Jingfei MaFrom the Departments of Cancer Systems Imaging (S.Z., A.K., M.D.P.), Abdominal Imaging (G.M.R., R.M.M.M., A.H.A., N.A.E.), Breast Imaging (B.E.A., M.B.), Imaging Physics (J.B.S., B.C.M., K.P.H., J.M., M.D.P.), Biostatistics (J.S., P.W.), and Breast Medical Oncology (J.B.W.), University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054; Department of Global MR Applications & Workflow, GE Healthcare Japan, Tokyo, Japan (M.M.); and Department of Global MR Applications & Workflow, GE Healthcare, Houston, TX (X.W.).ORCID 0000-0003-2827-8891
Mark D PagelFrom the Departments of Cancer Systems Imaging (S.Z., A.K., M.D.P.), Abdominal Imaging (G.M.R., R.M.M.M., A.H.A., N.A.E.), Breast Imaging (B.E.A., M.B.), Imaging Physics (J.B.S., B.C.M., K.P.H., J.M., M.D.P.), Biostatistics (J.S., P.W.), and Breast Medical Oncology (J.B.W.), University of Texas MD Anderson Cancer Center, 1881 East Rd, Houston, TX 77054; Department of Global MR Applications & Workflow, GE Healthcare Japan, Tokyo, Japan (M.M.); and Department of Global MR Applications & Workflow, GE Healthcare, Houston, TX (X.W.).ORCID 0000-0002-8109-3995
Funding
Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8MDevelopment and Dissemination of Clinical CEST MRI Acquisition and Analysis Methods for Cancer Imaging ApplicationsR01CA231513 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MA, JINGFEI, PAGEL, MARK DAVID · 2019 to 2023
$3.1MNCI NIH HHS P30 CA016672NCI NIH HHS R01 CA231513
Abstract
Purpose To determine if amide proton transfer-weighted chemical exchange saturation transfer (APT
Indexed as
ProtonsTriple Negative Breast NeoplasmsAmidesHumansMagnetic Resonance ImagingMiddle AgedNeoadjuvant TherapyPilot ProjectsProspective StudiesAmidesProtonsBreastMolecular Imaging-CancerMolecular Imaging-Clinical TranslationMR-ImagingTechnical AspectsTechnology AssessmentTumor Response
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.